Oropharynx Cancer clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
open to eligible people ages 18 years and up
This is a single-arm, observational registry study determining the effects of reduced radiation dose in select patients with human papillomavirus (HPV) positive oropharyngeal cancer.
Orange, California
Our lead scientists for Oropharynx Cancer research studies include Allen Chen.
Last updated: